BioVie Inc. (BIVI) Financials

BIVI Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 21.5 million 14.0 million
2023-09-30 23.8 million 16.2 million
2023-06-30 35.1 million 19.8 million
2023-03-31 45.2 million 23.5 million

BIVI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -5.9 million 922874
2023-09-30 -12.2 million 1.2 million
2023-06-30 -11.3 million 1.3 million
2023-03-31 -11.7 million 906534

BIVI Net Income

No data available :(

BIVI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 20.2 million - 65835
2023-09-30 21.2 million - 76769
2023-06-30 33.9 million - 87414
2023-03-31 43.8 million - 97779

BIVI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 38.2 million
2023-09-30 36.7 million
2023-06-30 36.3 million
2023-03-31 35.3 million

BIVI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 6.5 million 2.3 million -
2023-09-30 - 8.9 million 1.9 million -
2023-06-30 - 8.3 million 2.6 million -
2023-03-31 - 11.2 million 2.5 million -

BIVI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 57344
2023-09-30 - 67385
2023-06-30 - 67104
2023-03-31 - 66833

BIVI

Price: $0.50

52 week price:
0.45
8.69

Earnings Per Share: -1.17 USD

P/E Ratio: -0.79

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 123600

Market Capitalization: 28.0 million

Links: